Janssen Research and Development LLC

Research and development company of Johnson & Johnson, registered in the United States with sites at Titusville, Raritan and Spring House in New Jersey and Pennsylvania, at San Diego and in Beerse in Belgium, and since 2023 part of Johnson & Johnson Innovative Medicine. Runs discovery research, translational science, clinical development, biostatistics and data management, regulatory affairs and safety for medicines in oncology, immunology, neuroscience, infectious diseases and vaccines, cardiovascular and metabolic disease and pulmonary hypertension.